Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist

CompletedOBSERVATIONAL
Enrollment

131

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

March 31, 2009

Conditions
Sterility
Interventions
DRUG

hMG-HP

DRUG

hMG + GnRH antagonist

Trial Locations (7)

Unknown

Investigational site, Barcelona

Investigational site, Ciudad Real

Investigational site, Girona

Investigational site, La Rioja

Investigational site, Navarra

Investigational site, Reus

Investigational site, Valladolid

Sponsors
All Listed Sponsors
collaborator

Ferring SAU

INDUSTRY

lead

Ferring Pharmaceuticals

INDUSTRY

NCT01331733 - Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist | Biotech Hunter | Biotech Hunter